Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06263452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 29, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contact updated Eligibility criteria expanded, about 3 wordsv4 Show 1 more changeShow less
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Mar 2026 to May 2026 · Start date changed from estimate of Mar 2024 to May 1, 2024 · Site details revisedv3 Show 3 more changesShow less
    • Primary and study completion dates: Mar 2026 to May 2026
    • Start date changed from estimate of Mar 2024 to May 1, 2024
    • Site details revised
  3. Primary and study completion dates: Feb 2026 to Mar 2026 Start date: Feb 2024 to Mar 2024v2 Show 1 more changeShow less
    • Start date: Feb 2024 to Mar 2024
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to map the neural and molecular mechanisms underlying psychological stress-induced changes in inflammation which could reveal new targets for intervention to reduce the risk of cardiovascular disease.
Trial Details
NCT Number NCT06263452
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, Dartmouth College
Conditions Cardiovascular Disease
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov